Review Article
Impact of Timing following Acute Myocardial Infarction on Efficacy and Safety of Bone Marrow Stem Cells Therapy: A Network Meta-Analysis
Figure 4
The multiple comparisons of stem cells therapy among different timing groups for major adverse cardiac events. (a) The multiple-treatment meta-analysis of major adverse cardiac events based on data of 6-month and 12-month follow-up according to grouping method 1. (b) The hierarchical rank of timing group for the incidence of major adverse cardiac events based on data of 6-month follow-up according to grouping method 1. (c) The hierarchical rank of timing group for the incidence of major adverse cardiac events based on data of 12-month follow-up according to grouping method 1. (d) The multiple-treatment meta-analysis of major adverse cardiac events based on data of 6-month and 12-month follow-up according to grouping method 2. (e) The hierarchical rank of timing group for the incidence of major adverse cardiac events based on data of 6-month follow-up according to grouping method 2. (f) The hierarchical rank of timing group for the incidence of major adverse cardiac events based on data of 12-month follow-up according to grouping method 2.
(a) |
(b) |
(c) |
(d) |
(e) |
(f) |